Your search returned 4 results.

Results
	1.	The platelet hyporesponsiveness to clopidogrel in acute coronary syndrome patients treated with 75 mg/day clopidogrel may be overcome within 1 month of treatment. [electronic resource] by Kalantzi, Kallirroi I Dimitriou, Andromachi A Goudevenos, John A Tselepis, Alexandros D Producer: 20120822 In: Platelets vol. 23 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2.	Effect of clopidogrel besylate on platelet reactivity in patients with acute coronary syndromes. Comparison with clopidogrel hydrogen sulfate. [electronic resource] by Tsoumani, Maria E Kalantzi, Kallirroi I Dimitriou, Andromachi A Ntalas, Ioannis V Goudevenos, Ioannis A Tselepis, Alexandros D Producer: 20120508 In: Expert opinion on pharmacotherapy vol. 13 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	3.	Antiplatelet efficacy of long-term treatment with clopidogrel besylate in patients with a history of acute coronary syndrome: comparison with clopidogrel hydrogen sulfate. [electronic resource] by Tsoumani, Maria E Kalantzi, Kallirroi I Dimitriou, Andromachi A Ntalas, Ioannis V Goudevenos, Ioannis A Tselepis, Alexandros D Producer: 20121119 In: Angiology vol. 63 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	4.	The effects of rosuvastatin alone or in combination with fenofibrate or omega 3 fatty acids on inflammation and oxidative stress in patients with mixed dyslipidemia. [electronic resource] by Agouridis, Aris P Tsimihodimos, Vasilis Filippatos, Theodosios D Dimitriou, Andromachi A Tellis, Costantinos C Elisaf, Moses S Mikhailidis, Dimitri P Tselepis, Alexandros D Producer: 20120228 In: Expert opinion on pharmacotherapy vol. 12 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)